The NY Center for the Prevention of Heart Disease has announced an expanded approach to cardiovascular risk assessment, moving beyond exercise stress testing toward advanced imaging, as major medical guidelines recommend against using the test to screen people without symptoms.
-- The NY Center for the Prevention of Heart Disease has announced an expanded approach to cardiovascular risk assessment for people without symptoms, moving beyond exercise stress testing toward advanced imaging and cholesterol analysis. The center says many heart attacks originate from non-obstructive plaques that rupture suddenly, a mechanism standard stress testing is not designed to detect.
More information is available at https://www.thenyheartcenter.com
The limitations of stress testing are well documented. A standard stress test is designed to detect blockages that narrow an artery by 70 percent or more, according to Harvard Health Publishing, which notes heart attacks frequently result from smaller blockages that rupture rather than the severe narrowing the test is built to catch. A normal result cannot rule out that kind of rupture occurring later, explains the center, which is why the U.S. Preventive Services Task Force and the American College of Cardiology do not recommend routine stress testing for asymptomatic people. Furthermore, a landmark study in The Lancet found nine modifiable risk factors, including cholesterol, blood pressure and smoking, account for roughly 90 percent of the population-level risk of a first heart attack, meaning that stress testing should only be considered as one part of a broader diagnostic process.
The NY Center for the Prevention of Heart Disease's approach combines Coronary CT Angiography with Cleerly and HeartFlow artificial intelligence analysis, along with advanced cholesterol testing through Boston Heart Diagnostic Labs, to look for plaque and risk markers before symptoms develop. According to the center, standard cholesterol testing misses over half of those at significant risk for a heart attack or stroke, and over half of heart attacks occur as the first sign of disease, without warning. This, again, stresses the need for broad-spectrum testing to provide accurate risk levels.
The center is led by Dr. Bradley Radwaner, a board-certified cardiologist with more than 30 years of experience in preventive cardiology, on staff at Lenox Hill Hospital and a Clinical Assistant Professor of Medicine at NYU Langone. Radwaner has said the goal is identifying hidden cardiovascular risk before symptoms appear, rather than waiting for chest pain to prompt evaluation. Advanced imaging does not replace ongoing primary care, and decisions about additional testing should involve a qualified healthcare provider.
New York City-area residents interested in advanced cardiovascular risk assessment can schedule a consultation with The NY Center for the Prevention of Heart Disease at https://www.thenyheartcenter.com
Contact Info:
Name: Dr Radwaner
Email: Send Email
Organization: The NY Center for the Prevention of Heart Disease
Address: 136 East 57th Street, Suite 1001 Suite 1001, New York, NY 10022, United States
Phone: +1-212-717-0666
Website: https://www.thenyheartcenter.com/
Source: PressCable
Release ID: 89201628
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.